Table of Contents
1.1 List of Tables 6
1.2 List of Figures 12
2 Introduction 13
2.1 Aortic Stent Grafts Overview 13
3 Products under Development 14
3.1 Aortic Stent Grafts – Pipeline Products by Stage of Development 14
3.2 Aortic Stent Grafts – Pipeline Products by Segment 15
3.3 Aortic Stent Grafts – Pipeline Products by Territory 16
3.4 Aortic Stent Grafts – Pipeline Products by Regulatory Path 17
3.5 Aortic Stent Grafts – Pipeline Products by Estimated Approval Date 18
3.6 Aortic Stent Grafts – Ongoing Clinical Trials 19
4 Aortic Stent Grafts – Pipeline Products under Development by Companies 20
4.1 Aortic Stent Grafts Companies – Pipeline Products by Stage of Development 20
4.2 Aortic Stent Grafts – Pipeline Products by Stage of Development 22
5 Aortic Stent Grafts Companies and Product Overview 24
5.1 Affluent Medical SA Company Overview 24
5.1.1 Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview 24
5.2 Altura Medical Inc Company Overview 27
5.2.1 Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.3 Angiolutions UG Company Overview 30
5.3.1 Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview 30
5.4 Aortica Corp Company Overview 31
5.4.1 Aortica Corp Pipeline Products & Ongoing Clinical Trials Overview 31
5.5 Ascyrus Medical LLC Company Overview 32
5.5.1 Ascyrus Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 32
5.6 BiFlow Medical Ltd Company Overview 35
5.6.1 BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
5.7 BioQ Devices Pty Ltd Company Overview 36
5.7.1 BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 36
5.8 Cardiatis SA Company Overview 37
5.8.1 Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview 37
5.9 Cook Medical Inc Company Overview 40
5.9.1 Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 40
5.10 Cordis Corp Company Overview 44
5.10.1 Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview 44
5.11 Cytograft Tissue Engineering Inc (Inactive) Company Overview 48
5.11.1 Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 48
5.12 Endologix Inc Company Overview 49
5.12.1 Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview 49
5.13 Endoluminal Sciences Pty Ltd. Company Overview 64
5.13.1 Endoluminal Sciences Pty Ltd. Pipeline Products & Ongoing Clinical Trials Overview 64
5.14 EndoSpan Ltd Company Overview 65
5.14.1 EndoSpan Ltd Pipeline Products & Ongoing Clinical Trials Overview 65
5.15 Evasc Medical Systems Corp Company Overview 68
5.15.1 Evasc Medical Systems Corp Pipeline Products & Ongoing Clinical Trials Overview 68
5.16 Hadassah Medical Center Company Overview 69
5.16.1 Hadassah Medical Center Pipeline Products & Ongoing Clinical Trials Overview 69
5.17 JOTEC GmbH Company Overview 70
5.17.1 JOTEC GmbH Pipeline Products & Ongoing Clinical Trials Overview 70
5.18 Kawasumi Laboratories Inc Company Overview 79
5.18.1 Kawasumi Laboratories Inc Pipeline Products & Ongoing Clinical Trials Overview 79
5.19 Lifetech Scientific (Shenzhen) Co Ltd Company Overview 80
5.19.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 80
5.20 Lombard Medical Technologies Inc. Company Overview 81
5.20.1 Lombard Medical Technologies Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
6 Aortic Stent Grafts- Recent Developments 142
6.1 Nov 19, 2019: Medtronic reports second quarter financial results for the year 2019 142
6.2 Nov 14, 2019: Medtronic highlights leadership in inclusion, diversity, and equity in 2019 integrated performance report 144
6.3 Nov 13, 2019: Abbott announces Robert B. Ford to Succeed Miles D. White as Chief Executive Officer on March 31, 2020 145
6.4 Nov 12, 2019: W. L. Gore & Associates to reveal new gender insights from real-world aortic data At 2019 VEITHsymposium 146
6.5 Nov 12, 2019: Cook Medical’s leadership updates in Asia-pacific reinforce focus on growth and physician relationships 147
7 Appendix 234
7.1 Methodology 234
7.2 About GlobalData 237
7.3 Contact Us 237
7.4 Disclaimer 237
Table 1: Aortic Stent Grafts - Pipeline Products by Stage of Development
Table 2: Aortic Stent Grafts - Pipeline Products by Segment
Table 3: Aortic Stent Grafts - Pipeline Products by Territory
Table 4: Aortic Stent Grafts - Pipeline Products by Regulatory Path
Table 5: Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
Table 6: Aortic Stent Grafts - Ongoing Clinical Trials
Table 7: Aortic Stent Grafts Companies - Pipeline Products by Stage of Development
Table 8: Aortic Stent Grafts - Pipeline Products by Stage of Development
Table 9: Affluent Medical SA Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Kardiozis - Product Status
Table 11: Kardiozis - Product Description
Table 12: Affluent Medical SA - Ongoing Clinical Trials Overview
Table 13: Kardiozis - Prevention of Type II Endoleaks During Endovascular Treatment of Abdominal Aortic Aneurysm: Endovascular Treatment Versus Combination with Coil Embolisation of the Aneurysmal Sac
Table 14: Altura Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Altura Endograft System - Product Status
Table 16: Altura Endograft System - Product Description
Table 17: Altura Medical Inc - Ongoing Clinical Trials Overview
Table 18: Altura Endograft System - Kissing Endografts for Peripheral AAA Exclusion: ELEVATE International
Table 19: Altura Endograft System - Multi-center Observational Post-market Real World Registry
Table 20: Altura Endograft System - The Altura AAA Endograft Safety and Feasibility Study For Exclusion of Abdominal Aortic Aneurysms
Table 21: Angiolutions UG Pipeline Products & Ongoing Clinical Trials Overview
Table 22: Vascular Graft (A3-Shield) - Product Status
Table 23: Vascular Graft (A3-Shield) - Product Description
Table 24: Aortica Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 25: BoulEVARd Stent - Product Status
Table 26: BoulEVARd Stent - Product Description
Table 27: Ascyrus Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 28: Ascyrus Medical Dissection Stent - Product Status
Table 29: Ascyrus Medical Dissection Stent - Product Description
Table 30: Ascyrus Medical LLC - Ongoing Clinical Trials Overview
Table 31: Ascyrus Medical Dissection Stent - Dissected Aorta Repair Through Stent Implantation (DARTS): A Feasibility Study
Table 32: Ascyrus Medical Dissection Stent - Dissected Aorta Repair through Stent Implantation (DARTS): A Post-market Registry
Table 33: Ascyrus Medical Dissection Stent - Dissected Aorta Repair Through Stent Implantation: A Feasibility, Safety and Performance Trial: DARTS
Table 34: BiFlow Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 35: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Status
Table 36: Stainless Steel Nitinol Two-Way Shape Memory Stent - Product Description
Table 37: BioQ Devices Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 38: BioQ Aortic Stent Graft Assist - Product Status
Table 39: BioQ Aortic Stent Graft Assist - Product Description
Table 40: Cardiatis SA Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Bifurcated Multilayer Flow Modulator Kit - Product Status
Table 42: Bifurcated Multilayer Flow Modulator Kit - Product Description
Table 43: Cardiatis SA - Ongoing Clinical Trials Overview
Table 44: Bifurcated Multilayer Flow Modulator Kit - Evaluation of Safety and Efficacy of the Bifurcated Multilayer Flow Modulator: BMFM
Table 45: Cook Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 46: Zenith p-Branch - Product Status
Table 47: Zenith p-Branch - Product Description
Table 48: Cook Medical Inc - Ongoing Clinical Trials Overview
Table 49: Zenith p-Branch - Evaluation of Visceral Function Following Fenestrated Endovascular Aortic Aneurysm Repair (FEVAR) Using Branch Stent-Grafts
Table 50: Zenith p-Branch - Study Assessing Safety and Effectiveness of Perivisceral Aortic Aneurysm Treatment with the Zenith Fenestrated AAA Endovascular Graft and the Zenith p-Branch and the Effects on Organ and Extremity Perfusion
Table 51: Zenith p-Branch - Zenith p-Branch Multi-center Study
Table 52: Zenith p-Branch - Zenith p-Branch Pivotal Study
Table 53: Zenith p-Branch - Zenith p-Branch: Single-center Study
Table 54: Cordis Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 55: INCRAFT AAA Stent Graft - Product Status
Table 56: INCRAFT AAA Stent Graft - Product Description
Table 57: Cordis Corp - Ongoing Clinical Trials Overview
Table 58: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Non-randomized Study of the InCraft Stent Graft System in Subjects with Abdominal Aortic Aneurysms: INSPIRATION
Table 59: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post Approval Study of the INCRAFT Abdominal Aortic Aneurysm (AAA) Stent Graft System in Subjects with Abdominal Aortic Aneurysms
Table 60: INCRAFT AAA Stent Graft - A Multicenter, Open Label, Prospective, Post-market Study of the INCRAFT AAA Stent Graft in Subjects with Abdominal Aortic Aneurysms
Table 61: INCRAFT AAA Stent Graft - Korean Registry of Percutaneous EVAR with INCRAFT Stent Graft for the Treatment of Abdominalaortic Aneurysm (K-INCRAFT)
Table 62: Cytograft Tissue Engineering Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 63: LifeJacket AAA Stent Graft - Product Status
Table 64: LifeJacket AAA Stent Graft - Product Description
Table 65: Endologix Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 66: AFX2 Bifurcated Endograft System - Product Status
Table 67: AFX2 Bifurcated Endograft System - Product Description
List of Figures
Figure 1: Aortic Stent Grafts - Pipeline Products by Stage of Development
Figure 2: Aortic Stent Grafts - Pipeline Products by Segment
Figure 3: Aortic Stent Grafts - Pipeline Products by Territory
Figure 4: Aortic Stent Grafts - Pipeline Products by Regulatory Path
Figure 5: Aortic Stent Grafts - Pipeline Products by Estimated Approval Date
Figure 6: Aortic Stent Grafts - Ongoing Clinical Trials
【免責事項】
https://www.marketreport.jp/reports-disclaimer